Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06367556
Other study ID # 4542
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2024
Est. completion date October 1, 2028

Study information

Verified date April 2024
Source University Health Network, Toronto
Contact Lindsay Jibb, RN, PhD
Phone 416-813-7654
Email lindsay.jibb@sickkids.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this two-site phase III randomized controlled trial is to evaluate the effectiveness of a novel psychotherapeutic intervention called Emotion and Symptom-focused Engagement (EASE) in parents caring for a child or adolescent with cancer. The main question it aims to answer is: - Does EASE reduce traumatic stress symptom severity (primary outcome)? To do so, researchers will compare parents receiving EASE to usual care. Participants in both groups will complete questionnaires package at enrolment, and 4, 8, and 12 weeks, and 6 months after enrolment. They will also be invited to participate in optional qualitative interviews to better understand their experience.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 306
Est. completion date October 1, 2028
Est. primary completion date October 1, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Self-identified primary parental family caregiver/guardian (i.e., parent assuming the majority of care activities) of a child: i) diagnosed with a new or relapsed life-threatening cancer within the preceding six months (disease-type eligibility per the Pediatric Oncology Group of Ontario Networked Information System); ii) <18 years of age; and, iii) receiving active cancer therapy; - Age =18 years; and, - Able to complete outcome measures and engage in EASE in English, which need not be their first language. Exclusion Criteria: - Impairment in cognitive functioning or communication that would preclude participation in EASE sessions or outcome measure completion, as determined by the research team; - Receiving formal ongoing psychotherapy at the time of recruitment; - Active suicidal intention, based on an item in the Distress Assessment and Response Tool (DART) that has been widely used in suicidal intention screening in cancer; or, - Child not expected to survive past the duration of trial, as determined by the child's medical team.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
EASE
EASE sessions are directed to provide relational support, affect regulation, and problem-solving related to cancer in the child, to changes in spousal, family, and other relationships, and to the burden of multiple individual and family responsibilities.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University Health Network, Toronto Canadian Institutes of Health Research (CIHR), The Hospital for Sick Children

Outcome

Type Measure Description Time frame Safety issue
Other Traditional Masculinity-Femininity Scale [TMF] This will be used to assess gender role. Baseline
Other Caregiver Reaction Assessment Scale [CRA] This will be used to measure caregiver burden. 6-months
Other ENRICHD Social Support Instrument [ESSI] This will be used to measure perceived social support. 6-months
Other Experiences in Close Relationships Scale [ECR-16] This will be used to measure attachment security. 6-months
Other Hope of Improvement subscale of the Therapy Expectation and Evaluation Scale [PATHEVH] This will be used to assess expectation of EASE effectiveness in the treatment arm. Baseline
Primary Posttraumatic Stress Disorder Checklist for DSM-5 [PCL-5] This will be used to measure traumatic stress symptoms. 6-months
Secondary SF-36v2 Health Survey This will be used to measure quality of life. 6-months
Secondary Patient Health Questionnaire [PHQ-9] This will be used to measure depressive symptoms. 6-months
Secondary Caregiving Health Engagement Scale [CHE-s] This will be used to measure parent capacity to care for their child. 6-months
Secondary Family Adaptability and Cohesion Evaluation Scales III [FACES-III] This will be used to measure parent perceived family functioning. 6-months
Secondary Clinical Evaluation Questionnaire [CEQ] This will be used to measure parent perceived benefit from interaction with clinicians. 6-months
Secondary Family Satisfaction with End-of-Life Care Tool, 10-item version [FAMCARE-10] This will be used to measure parent satisfaction with care. 6-months
See also
  Status Clinical Trial Phase
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Not yet recruiting NCT06335745 - PediCARE Health Equity Intervention in High-Risk Neuroblastoma N/A
Withdrawn NCT04719416 - Relaxation Therapy in Pediatric Oncology N/A
Completed NCT01645436 - Physical Activity in Pediatric Cancer (PAPEC) N/A
Completed NCT04409301 - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation N/A
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05425043 - Granulocyte Transfusions After Umbilical Cord Blood Transplant N/A
Recruiting NCT05071859 - Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
Recruiting NCT03241251 - Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
Recruiting NCT05384288 - Response to Influenza Vaccination in Pediatric Oncology Patients
Completed NCT04586491 - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients N/A
Recruiting NCT05569512 - Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML Phase 1/Phase 2
Enrolling by invitation NCT05294380 - Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Completed NCT02675166 - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Completed NCT02665819 - Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility. N/A
Not yet recruiting NCT05454163 - Post-radiotherapy Rhinosinusitis in Children
Terminated NCT02536183 - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase 1
Withdrawn NCT01828502 - Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Phase 2
Completed NCT02032121 - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors N/A
Completed NCT03964259 - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Phase 1